Phocas Financial Corp. Purchases 19,123 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Phocas Financial Corp. increased its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 36.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 72,225 shares of the company’s stock after acquiring an additional 19,123 shares during the quarter. Phocas Financial Corp. owned about 0.08% of Acadia Healthcare worth $4,580,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. William Blair Investment Management LLC raised its stake in Acadia Healthcare by 20.7% during the second quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock worth $237,434,000 after acquiring an additional 604,070 shares in the last quarter. Point72 Asset Management L.P. grew its holdings in Acadia Healthcare by 266.0% in the second quarter. Point72 Asset Management L.P. now owns 2,270,340 shares of the company’s stock worth $153,339,000 after purchasing an additional 1,650,040 shares during the period. Bank of New York Mellon Corp raised its stake in Acadia Healthcare by 6.6% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,249,369 shares of the company’s stock worth $84,382,000 after buying an additional 77,509 shares during the period. Millennium Management LLC lifted its holdings in shares of Acadia Healthcare by 3,067.8% in the 2nd quarter. Millennium Management LLC now owns 1,090,313 shares of the company’s stock worth $73,640,000 after purchasing an additional 1,055,894 shares in the last quarter. Finally, Iron Triangle Partners LP increased its stake in Acadia Healthcare by 14.0% during the 1st quarter. Iron Triangle Partners LP now owns 902,813 shares of the company’s stock valued at $71,521,000 after purchasing an additional 110,820 shares in the last quarter.

Acadia Healthcare Trading Down 1.8 %

Shares of Acadia Healthcare stock opened at $37.13 on Tuesday. The company’s 50-day moving average price is $57.27 and its 200-day moving average price is $65.34. The company has a market cap of $3.45 billion, a price-to-earnings ratio of 12.17, a PEG ratio of 1.68 and a beta of 1.33. Acadia Healthcare Company, Inc. has a 12-month low of $36.50 and a 12-month high of $87.77. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. The business had revenue of $815.60 million for the quarter, compared to the consensus estimate of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter last year, the business posted $0.91 earnings per share. On average, equities analysts expect that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have issued reports on ACHC. Deutsche Bank Aktiengesellschaft lifted their price target on Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. Barclays reduced their price objective on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a research report on Monday, September 30th. Royal Bank of Canada dropped their price target on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating on the stock in a report on Monday. StockNews.com upgraded Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Thursday, November 14th. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $90.00 price objective on shares of Acadia Healthcare in a research report on Tuesday, October 1st. Five research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $83.33.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.